Impact factor molecular cancer therapeutics

Author: xtzu

August undefined, 2024

WitrynaThe latest impact factor of MOLECULAR CANCER THERAPEUTICS and all the other SCI journals was released on 30th June 2024 by Clarivate. Through this web page, … Witryna8 kwi 2024 · Attenuating aberrant transcriptional circuits holds great promise for the treatment of numerous diseases, including cancer. However, development of transcriptional inhibitors is hampered by the lack of a generally accepted functional cellular readout to characterize their target specificity and on-target activity. We …

Molecular Cancer Therapeutics OOIR

WitrynaImpact. 5.738 Impact Factor. 4.5 CiteScore. ... Cancer Molecular Targets and Therapeutics Cardio-Oncology Gastrointestinal Cancers: Colorectal Cancer ... Frontiers is well aware of the potential impact of published research both on future research and on society and, hence, does not support superficial review, light review or no-review ... WitrynaExperience in the developmental genetic factors affecting human brain disorders, rodent and non-rodent animal models and tumor … grand torino ireland gab

Dr Debasmita Mukhopadhyay, PhD - London Area, United …

Witryna30 cze 2024 · The impact factor for Cancer Discovery has more than tripled, and is now 39.397, according to Journal Citation Reports TM from Clarivate, 2024, released on Wednesday. “The incredible growth of the journal’s impact factor reflects Cancer Discovery’s importance to cancer researchers around the world,” said Foti. “The … WitrynaMy experience spans across molecular carcinogenesis, cancer stem cells, cancer signaling, chemo-resistance, target identification, … WitrynaSpecific Categories: Small Molecule Therapeutics: Discovery and preclinical development of small molecule entities. Large Molecule Therapeutics: Novel large … grand torino game

Molecular Oncology - Wiley Online Library - FEBS Press

MOLECULAR CANCER THERAPEUTICS - Impact Factor, Acceptance …

WitrynaMolecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews … Witryna15 June 2024. About the journal. Aims & Scope. Molecular Therapy Oncolyticsis an international, online-only, open-access journal focusing on the development and … grand torino actorsWitrynaMolecular Cancer Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1476-4598. ... About Molecular Cancer. Molecular Cancer is an open access, peer-reviewed online journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer ... chinese roxborough

"WitrynaMolecular Cancer. -Impact factor 2024 - 2024. The latest impact factor of Molecular Cancer and all the other SCI journals was released on 30th June 2024 by Clarivate. … " - Impact factor molecular cancer therapeutics

Impact factor molecular cancer therapeutics

WitrynaDr Lopamudra Das Roy (Distinguished Cancer Scientist-Research Professor), Social Entrepreneur, resigned from her rewarding career in 2024, to create and grow BCH as her Full-time pro bono ... WitrynaMolecular Cancer Therapeutics Citations: 16,563 Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the …

Did you know?

Witryna27 maj 2024 · The impact score (IS) 2024 of Molecular Cancer Therapeutics is 5.53, which is computed in 2024 as per its definition. Molecular Cancer Therapeutics IS is … Witryna6 paź 2024 · In this Editorial, Christine Watson highlights the content of The FEBS Journal ’s Special Issue on Cancer Therapeutics. Through an exciting collection of recent articles, this issue covers a broad repertoire of cancer therapeutic approaches. Several articles discuss broad-spectrum applications, such as immunotherapy and …

WitrynaMolecular Research on Pancreatic Cancer: Current Trends and New Perspectives (Deadline: 15 April 2024) Kinases and Other Molecular Targets in Cancer: Recent … WitrynaSelect an AACR Journal The nine AACR journals vary in scope and selectivity. If you are unsure which journal would be most appropriate for your manuscript, please review …

Witryna27 maj 2024 · The impact score (IS) 2024 of Molecular Cancer Therapeutics is 5.53, which is computed in 2024 as per its definition.Molecular Cancer Therapeutics IS is increased by a factor of 0.26 and approximate percentage change is 4.93% when compared to preceding year 2024, which shows a rising trend. The impact score (IS), … WitrynaJournal impact factor : 0.53 ; Average acceptance to publication time (5-7 days) Average article processing time (30-45 days) Less than 5 volumes 30 days ... Biochimica et Biophysica Acta - Reviews on Cancer, Breast Cancer Research, Neuro-Oncology, Molecular Cancer Therapeutics, Cancer, Journal of Thoracic Oncology.

Witryna19 lut 2024 · Molecular Therapy ISSN 1525-0016 (online) Methods & Clinical Development ISSN 2329-0501 (online) Nucleic Acids ISSN 2162-2531 (online) Oncolytics ISSN 2372-7705 (online) The content on this site is intended for healthcare professionals and researchers across all fields of science.

WitrynaThis special issue published by Molecular Cancer focuses on the clinical aspects of liquid biopsies, in particular validation of novel biomarkers that may serve as signature … grand torino mha real nameWitrynaCitation Impact 41.444 - 2-year Impact Factor (2024) 30.612 - 5-year Impact Factor (2024) 5.195 - Source Normalized Impact per Paper (SNIP) 6.896 - SCImago Journal … grand torino cast and crewWitrynaMolecular Cancer Therapeutics. Journal Abbreviation: MOL CANCER THER. Journal ISSN: 1535-7163. Year. Impact Factor (IF) Total Articles. Total Cites. 2024 (2024 update) 6.009. chinese royal surnamesWitrynaMedical Researcher Horticultural Hobbyist Junior Scientist Transhumanist Research Focus: • Molecular and Genomic Medicine, CRISPR Cas-9 Associated Genomic Therapy • Viral Therapeutics, Viral vector development, Developments of Novel Platforms for Investigations of Infections with Unknown Aetiology • Emerging … grand torino directorWitrynaImpact Factor Cancer Discovery: 41.226 Cancer Epidemiology, Biomarkers & Prevention: 5.594 Cancer Immunology Research: 13.345 Cancer Prevention Research: 4.317 … grand torino movie 2018 freeWitryna总结了一下我见过的爱发molcular cancer组的特点：. 组内科研风气浮躁，天天嘴里一口一个大文章，然后爱攀比文章数量多少，总因子多少，各种张院士李院士互相追捧，一会你发了大文章富贵了，一会儿我分没你高我完蛋了。. 而且喜欢发oa期刊，几乎没有原创 ... chinese royal kitchenWitryna2 dni temu · Start your submission and get more impact for your research by publishing with us. Author guidelines. Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript. ... Cancer Molecular Targets and Therapeutics wafik s. … chinese royals